ClinicalTrials.Veeva

Menu

Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast Cancer (Phi-Bra)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Breast Neoplasm Female

Treatments

Device: Phi-Bra prototype measurements

Study type

Interventional

Funder types

Other

Identifiers

NCT05574816
69HCL21_1085

Details and patient eligibility

About

Phi-Bra is a prospective and monocentric pilot study to assess the diagnostic capability of an innovative bra prototype to detect breast cancer, compared to the current standard of care: the mammography.

The Phi-Bra prototype is designed with sensors measuring different parameters simultaneously such as impedance and temperature.

The bra will be tested on patients without breast lump (American College of Radiology (ACR) 1 et 2 Birads classification) and with breast lump (ACR 4b, c ou ACR 5 Birads classification).

The aim of this pilot study is to compare the results obtained by Phi-Bra to the ones obtained by mammography.

The Phi-Bra study is classified as clinical investigation category 4.4 based on the European Union (EU) regulation (DM 2017/745).

Enrollment

45 patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 75.
  • No breast cancer surgery background
  • Bra size : S/M or M/L

Specific criteria for the "no breast lump" cohort:

  • Negative mammography result (ACR 1 a 2).

Specific criteria for the "breast lump" cohort:

  • Suspicious breast lump discovered during the mammography (ACR 4b ou c ou ACR 5) and for which there is an indication of microbiopsy.

Exclusion criteria

  • Breast cancer background (surgery or radiotherapy)
  • Breast lump classified as ACR 3 ou ACR 4a during the mammography

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 2 patient groups

Patient without breast lump
Active Comparator group
Description:
No breast lump identified during mammography (ACR 1 et 2 Birads classification)
Treatment:
Device: Phi-Bra prototype measurements
Patient with breast lump
Experimental group
Description:
Suspicious breast lump identified during mammography (ACR 4b, c ou ACR 5 Birads classification)
Treatment:
Device: Phi-Bra prototype measurements

Trial contacts and locations

2

Loading...

Central trial contact

Marion CORTET, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems